Human papillomavirus molecular biology and disease association

J Doorbar, N Egawa, H Griffin… - Reviews in medical …, 2015 - Wiley Online Library
Human papillomaviruses (HPVs) have evolved over millions of years to propagate
themselves in a range of different animal species including humans. Viruses that have co …

The Pap Test and Bethesda 2014 “The reports of my demise have been greatly exaggerated.”(after a quotation from Mark Twain)

R Nayar, DC Wilbur - Acta cytologica, 2015 - karger.com
Abstract The history of 'The Bethesda System'for reporting cervical cytology goes back
almost 3 decades. This terminology and the process that created it have had a profound …

[图书][B] Патология матки. Руководство для врачей

Н Кондриков, И Баринова - 2020 - books.google.com
В практическом пособии рассматриваются основные принципы морфологического
исследования при заболеваниях матки, гистофизиологические изменения шейки матки …

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

G Ronco, J Dillner, KM Elfström, S Tunesi, PJF Snijders… - The lancet, 2014 - thelancet.com
Background In four randomised trials, human papillomavirus (HPV)-based screening for
cervical cancer was compared with cytology-based cervical screening, and precursors of …

Human papillomavirus vaccination and cervical cancer risk

L Rahangdale, C Mungo, S O'Connor, CJ Chibwesha… - Bmj, 2022 - bmj.com
Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

[HTML][HTML] Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test

TC Wright, MH Stoler, CM Behrens, A Sharma… - Gynecologic …, 2015 - Elsevier
Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors

LS Massad, MH Einstein, WK Huh… - Journal of lower …, 2013 - journals.lww.com
ABSTRACT A group of 47 experts representing 23 professional societies, national and
international health organizations, and federal agencies met in Bethesda, MD, September …

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

M Arbyn, F Verdoodt, PJF Snijders, VMJ Verhoef… - The lancet …, 2014 - thelancet.com
Background Screening for human papillomavirus (HPV) infection is more effective in
reducing the incidence of cervical cancer than screening using Pap smears. Moreover, HPV …

The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of …

TM Darragh, TJ Colgan, JT Cox… - … of pathology & …, 2012 - meridian.allenpress.com
The terminology for human papillomavirus (HPV)–associated squamous lesions of the lower
anogenital tract has a long history marked by disparate diagnostic terms derived from …